Postnatal neuronal GPX4 deficiency exacerbates ferroptotic secondary brain injury after traumatic brain injury and is rescued by ferrostatin-1
Free Radic Biol Med. 2026 Nov 12:S0891-5849(26)01276-1. doi: 10.1016/j.freeradbiomed.2026.11.025. Online ahead of print. ABSTRACT Ferroptosis has emerged as an important component of secondary injury after traumatic brain injury (TBI), yet the in vivo contribution of neuronal glutathione peroxidase 4 (GPX4), the core lipid hydroperoxide detoxifying enzyme, remains incompletely defined. Here we used 10-12-week-old male Gpx4fl/fl;CamKII-Cre […]
Vitamin D receptor activation alleviates ferroptosis of lens epithelial cells in diabetic cataract by inhibiting NF-κB signaling
Mol Biol Rep. 2026 Nov 12;53(1):1952. doi: 10.1007/s11033-026-13156-0. ABSTRACT BACKGROUND: Diabetic cataract (DC) is a common ocular complication of diabetes recently linked to ferroptosis. Although the vitamin D receptor (VDR) is known to protect against ocular diseases by suppressing ferroptosis, its role in DC remains unclear. METHODS AND RESULTS: Lens epithelial tissues were collected from […]
Decreased substrate stiffness leads Endothelial to Mesenchymal transition through Focal Adhesion Kinase activity in corneal endothelial cells
Am J Pathol. 2026 Nov 12:S0002-9440(26)00317-2. doi: 10.1016/j.ajpath.2026.10.007. Online ahead of print. ABSTRACT Fuchs’ Endothelial Corneal Dystrophy (FECD), a degenerative corneal disorder, is marked by the thickening of Descemet’s membrane and a progressive loss of corneal endothelial cells, ultimately leading to vision loss. A feature associated with the disease is the reduced stiffness of Descemet’s […]
Transcranial photobiomodulation influences BOLD responses during finger sequence execution: An fMRI Study in young and older adults
Neuroimage. 2026 Nov 11:122351. doi: 10.1016/j.neuroimage.2026.122351. Online ahead of print. ABSTRACT Transcranial photobiomodulation (PBM) is an emerging non-invasive brain stimulation method that is thought to increase neural metabolism by stimulating ATP production by the mitochondria. However, the mechanisms of action and the effects on the human brain are still unclear. In the present study, we […]
Mitochondrial protein import stress augments alpha-synuclein aggregation and neural damage
Life Sci Alliance. 2026 Nov 10;10(1):e202603770. doi: 10.26508/lsa.202603770. Print 2027 Jan. ABSTRACT Genetic and environmental factors are known to converge on mitochondria to cause Parkinson’s disease. The underlying mechanism is incompletely understood. In addition to bioenergetic defects, nonbioenergetic pathways have been largely unexplored. Validating the nonbioenergetic mitochondrial stressors as independent pathogenic factors is challenging because […]
Translational lipidomics in glaucoma: mechanisms, biomarkers, and therapeutic horizons
Front Pharmacol. 2026 Oct 26;17:1921097. doi: 10.3389/fphar.2026.1921097. eCollection 2026. ABSTRACT Glaucoma is a multifactorial optic neuropathy. Intraocular pressure (IOP), aging, vascular dysregulation, oxidative stress, mitochondrial failure, and chronic neuroinflammation converge on retinal ganglion cell (RGC) degeneration and optic nerve damage. Lipid mediators are central to this biology, linking membrane remodeling to aqueous humor (AH) dynamics, […]
A Bioengineered Mitochondrial Respiration-Mimetic Copper-Based Metal-Organic Framework Reprogramming Oxidative Phosphorylation to Enhance Tumor Cuproptosis
Adv Sci (Weinh). 2026 Nov 9:e78669. doi: 10.1002/advs.78669. Online ahead of print. ABSTRACT Mitochondrial metabolism-dependent cuproptosis has emerged as a promising anticancer modality, yet its efficacy is constrained by the hypoxic and glycolysis-dominant tumor microenvironment that suppresses oxidative phosphorylation (OXPHOS). Strategies that simultaneously overcome hypoxia and mitochondrial metabolic resistance remain underexplored. Herein, we report a […]
Rare genetic variants in leber hereditary optic neuropathy: molecular mechanisms, diagnosis, and emerging therapies
Doc Ophthalmol. 2026 Nov 9. doi: 10.1007/s10633-026-10166-y. Online ahead of print. ABSTRACT Hereditary optic neuropathies, such as Leber’s hereditary optic neuropathy (LHON), remain a focus of active research. Diagnostic challenges and severe clinical consequences often result in atypical presentations, creating significant obstacles for neuro-ophthalmology. The field has garnered increased attention due to advances in molecular […]
An update on pharmacotherapies and emerging therapeutic approaches for geographic atrophy
Expert Opin Pharmacother. 2026 Nov 8. doi: 10.1080/14656566.2026.2761125. Online ahead of print. ABSTRACT INTRODUCTION: Geographic atrophy (GA) secondary to age-related macular degeneration is a leading cause of irreversible vision loss. The 2023 FDA approvals of pegcetacoplan and avacincaptad pegol were a milestone, but modest anatomic benefit without demonstrated prespecified functional benefit, increased neovascular conversion, and […]
Decellularized Amniotic Membrane-Mesenchymal Stem Cell Composite Enhances Corneal Repair via Mitochondrial Bioenergetics Restoration
ACS Appl Mater Interfaces. 2026 Nov 6. doi: 10.1021/acsami.6c15983. Online ahead of print. ABSTRACT Corneal alkali burn causes persistent inflammation, fibrosis, neovascularization, and vision impairment. Although amniotic membrane (AM) transplantation and mesenchymal stem cell (MSC)-based therapies have shown therapeutic potential, their combined application as a tissue-engineered construct for alkali-induced corneal injury remains insufficiently explored. Here, […]